1. Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous cycles for in vitro fertilization?
- Author
-
Aarti Bhasin, Laura Londra, Caroline Moreau, Donna M. Strobino, and Yulian Zhao
- Subjects
Adult ,0301 basic medicine ,Agonist ,endocrine system ,medicine.medical_specialty ,medicine.drug_class ,medicine.medical_treatment ,Fertilization in Vitro ,Gonadotropin-releasing hormone ,Luteal phase ,Fertility Agents ,Gonadotropin-Releasing Hormone ,Andrology ,03 medical and health sciences ,Hormone Antagonists ,0302 clinical medicine ,Ovulation Induction ,Pregnancy ,Risk Factors ,Internal medicine ,Odds Ratio ,Humans ,Medicine ,030219 obstetrics & reproductive medicine ,In vitro fertilisation ,Assisted reproductive technology ,Ectopic pregnancy ,business.industry ,Obstetrics and Gynecology ,Odds ratio ,Embryo Transfer ,medicine.disease ,Embryo transfer ,Pregnancy, Ectopic ,Fertility ,Logistic Models ,Treatment Outcome ,030104 developmental biology ,Endocrinology ,Reproductive Medicine ,Infertility ,Multivariate Analysis ,Female ,business ,hormones, hormone substitutes, and hormone antagonists - Abstract
Objective To evaluate the association between different ovarian hyperstimulation protocols and ectopic pregnancy (EP) in in vitro fertilization (IVF) cycles in fresh autologous embryo transfer cycles in the United States between 2008 and 2011 as reported to the Society of Assisted Reproductive Technology (SART). Design Historical cohort study. Setting Not applicable. Patient(s) None. Intervention(s) None. Main Outcome Measure(s) All autologous cycles that resulted in a clinical pregnancy after a fresh, intrauterine embryo transfer and described characteristics of cycles according to protocol were included: luteal GnRH agonist, GnRH agonist flare, or GnRH antagonist. Multivariate logistic regression was conducted to investigate the association between type of protocol and EP. Result(s) Among 136,605 clinical pregnancies, 2,645 (1.94%) were EP. Ectopic pregnancy was more frequent with GnRH antagonist (2.4%) cycles than with GnRH agonist flare (2.1%) or luteal GnRH agonist (1.6%) cycles. After adjusting for maternal and treatment characteristics, the GnRH antagonist and the GnRH agonist flare protocols were associated with increased odds of EP (adjusted odds ratio [aOR] 1.52; 95% confidence interval [CI], 1.39–1.65; and aOR 1.25; 95% CI, 1.09–1.44, respectively) compared with luteal GnRH agonist. Analysis of differences in the factors related to EP in luteal GnRH agonist versus GnRH antagonist protocols indicated that diminished ovarian reserve was associated with an increased risk of EP in luteal GnRH agonist but not in GnRH antagonist cycles. Conclusion(s) The type of protocol used during ovarian hyperstimulation in fresh autologous cycles was associated with EP. This finding suggests a role for extrapituitary GnRH on the tubal and uterine environment during ovarian hyperstimulation treatment for IVF.
- Published
- 2016
- Full Text
- View/download PDF